Intervisit variability of visual parameters in Leber congenital amaurosis caused by RPE65 mutations
- PMID: 23341016
- PMCID: PMC3597193
- DOI: 10.1167/iovs.12-11341
Intervisit variability of visual parameters in Leber congenital amaurosis caused by RPE65 mutations
Abstract
Purpose: To determine the intervisit variability of kinetic visual fields and visual acuity in patients with Leber congenital amaurosis (LCA) caused by mutations in the RPE65 (Retinal Pigment Epithelium-specific protein 65kDa) gene.
Methods: RPE65-LCA patients (n = 20; ages 11-40 years) were studied on at least two visits separated by fewer than 120 days using Goldmann visual field (GVF) and ETDRS visual acuity (VA) in a retrospective review. GVFs were quantified by computing the spherical coordinates of their vertices and calculating the solid angle subtended, and reported in normalized solid-angle units (nsu) as a percentage of average normal field extent. Repeatability coefficients were calculated using 95% confidence intervals on log(10)-converted variables.
Results: Visual field extents in RPE65-LCA spanned a wide range from 4 to 95 nsu. The repeatability coefficient was 0.248 (log(10)nsu), suggesting cutoffs for significant change (in nsu) of +77% for improvement and -44% for worsening. VA in RPE65-LCA ranged from logMAR = 0.14 to 1.96 (20/40 to 20/1250). The repeatability coefficient was 0.170 (logMAR) (±8.5 ETDRS letters). Comparisons with published studies of ungenotyped retinitis pigmentosa showed that the RPE65-LCA patients had higher variability in kinetic field extent. VA variability in RPE65-LCA fell within reported results for retinitis pigmentosa.
Conclusions: Variability data for GVF and VA are provided to permit interpretation of the significance of increases and decreases of these functional outcomes in ongoing and planned clinical trials of therapy for LCA caused by RPE65 mutations.
Conflict of interest statement
Disclosure:
Figures


Similar articles
-
RPE65 mutations in Leber congenital amaurosis, early-onset severe retinal dystrophy, and retinitis pigmentosa from a tertiary eye care center in India.Ophthalmic Genet. 2024 Jun;45(3):303-312. doi: 10.1080/13816810.2024.2309559. Epub 2024 Feb 7. Ophthalmic Genet. 2024. PMID: 38323530
-
Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial.Lancet. 2014 Oct 25;384(9953):1513-20. doi: 10.1016/S0140-6736(14)60153-7. Epub 2014 Jul 13. Lancet. 2014. PMID: 25030840 Clinical Trial.
-
A Cross-Sectional and Longitudinal Study of Retinal Sensitivity in RPE65-Associated Leber Congenital Amaurosis.Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3330-3339. doi: 10.1167/iovs.18-23873. Invest Ophthalmol Vis Sci. 2018. PMID: 30025081 Free PMC article.
-
Cone-rod dystrophy caused by a novel homozygous RPE65 mutation in Leber congenital amaurosis.Klin Monbl Augenheilkd. 2014 Apr;231(4):405-10. doi: 10.1055/s-0034-1368221. Epub 2014 Apr 25. Klin Monbl Augenheilkd. 2014. PMID: 24771178 Review.
-
The effect of human gene therapy for RPE65-associated Leber's congenital amaurosis on visual function: a systematic review and meta-analysis.Orphanet J Rare Dis. 2020 Feb 14;15(1):49. doi: 10.1186/s13023-020-1304-1. Orphanet J Rare Dis. 2020. PMID: 32059734 Free PMC article.
Cited by
-
Long-term experience with gene augmentation therapy in patients with inherited retinal disease associated with biallelic mutations in RPE65.Med Genet. 2025 Feb 12;37(1):47-56. doi: 10.1515/medgen-2024-2067. eCollection 2025 Apr. Med Genet. 2025. PMID: 39943983 Free PMC article.
-
Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy.Mol Ther. 2021 Feb 3;29(2):442-463. doi: 10.1016/j.ymthe.2020.11.029. Epub 2020 Dec 3. Mol Ther. 2021. PMID: 33278565 Free PMC article. Review.
-
Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials.PLoS One. 2015 Apr 24;10(4):e0125700. doi: 10.1371/journal.pone.0125700. eCollection 2015. PLoS One. 2015. PMID: 25909963 Free PMC article.
-
Safety and Proof-of-Concept Study of Oral QLT091001 in Retinitis Pigmentosa Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT).PLoS One. 2015 Dec 10;10(12):e0143846. doi: 10.1371/journal.pone.0143846. eCollection 2015. PLoS One. 2015. PMID: 26656277 Free PMC article. Clinical Trial.
-
Reliability of Semiautomated Kinetic Perimetry (SKP) and Goldmann Kinetic Perimetry in Children and Adults With Retinal Dystrophies.Transl Vis Sci Technol. 2019 Jun 11;8(3):36. doi: 10.1167/tvst.8.3.36. eCollection 2019 May. Transl Vis Sci Technol. 2019. PMID: 31211001 Free PMC article.
References
-
- Jacobson SG, Cideciyan AV. Treatment possibilities for retinitis pigmentosa. N Engl J Med. 2010; 363: 1669–1671 - PubMed
-
- Fishman GA, Jacobson SG, Alexander KR, et al. Outcome measures and their application in clinical trials for retinal degenerative diseases: outline, review, and perspective. Retina. 2005; 25: 772–777 - PubMed
-
- Bramall AN, Wright AF, Jacobson SG, McInnes RR. The genomic, biochemical, and cellular responses of the retina in inherited photoreceptor degenerations and prospects for the treatment of these disorders. Annu Rev Neurosci. 2010; 33: 441–472 - PubMed
-
- Wright AF, Chakarova CF, Abd El-Aziz MM, Bhattacharya SS. Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait. Nat Rev Genet. 2010; 11: 273–284 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials